▲ Peaking
Business
🔮 holds
FDA approves Otsuka’s ADHD drug Simtriyo, teeing up its ‘next major CNS launch’
Otsuka's ADHD drug Simtriyo gains FDA approval, opening a new market segment.
Fda Approval
4 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✗
US FDA approves over-the-counter Tylenol combination pill for pain relief
The US FDA has approved the first over-the-counter combination of acetaminophen and naproxen for extended pain relief.
◼ Archived
Business
🔮 fades ✗
Eli Lilly’s Anticipated Weight Loss Drug Helped People Lose 56 Pounds On Average
Eli Lilly's retatrutide shows promising results in weight loss trials, driving stock gains and regulatory anticipation
◼ Archived
Business
🔮 fades ✗
Alzheimer's: Real-world study confirms Leqembi therapy benefits
FDA approval of an at-home subcutaneous starter dose for Leqembi coincides with a real-world study confirming the therapy's benefits.